ℹ️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. It may contain affiliate links. Always consult your physician or pharmacist before making changes to your medications. Full disclosure policy.

Eligibility Requirements

Income Limit
Up to 400% of Federal Poverty Level
Insurance Requirements
Available to uninsured patients. Some programs available for underinsured and Medicare patients.

Covered Medications

The following medications are covered by AZ&Me Prescription Savings Program:

Farxiga Symbicort Tagrisso Lynparza Brilinta Calquence Imfinzi Breztri

What Makes AZ&Me Different

AZ&Me stands out among manufacturer patient assistance programs because it covers medications across an unusually broad range of therapeutic areas, from respiratory and cardiovascular drugs to advanced oncology treatments. Symbicort (budesonide/formoterol), one of the most commonly prescribed asthma and COPD inhalers, retails for $150 to $400 per month. Farxiga (dapagliflozin), used for type 2 diabetes, heart failure, and chronic kidney disease, costs approximately $550 per month at retail. For oncology patients, Tagrisso (osimertinib) carries a price tag above $15,000 per month. AZ&Me is also one of the few manufacturer programs that supports patients transitioning between brand and authorized generic alternatives within the AstraZeneca portfolio.

The program's income threshold sits at 400% of the Federal Poverty Level, which translates to roughly $60,240 per year for an individual or $124,800 for a family of four. Unlike many PAPs that only serve completely uninsured patients, AZ&Me has separate tracks for uninsured patients (free medication), Medicare patients without Low-Income Subsidy, and underinsured patients facing high out-of-pocket costs. This tiered structure means more patients can find a pathway to affordable medication. Approved patients typically receive a 90-day supply shipped directly to their home or prescriber's office, eliminating the need to visit a pharmacy for pickup.

When applying, keep in mind that AZ&Me processes applications faster than many competitors, with most decisions arriving within two to four weeks. However, each AstraZeneca medication may have slightly different eligibility criteria within the AZ&Me umbrella, so confirm coverage for your specific drug when you call 1-800-292-6363. Renewals are required periodically (typically every 12 months), and you will need to resubmit income documentation. If you are prescribed multiple AstraZeneca medications, a single application can cover all of them, which saves considerable paperwork compared to programs that require separate applications per drug.

How to Apply

Application Steps
  1. Speak with your healthcare provider about AZ&Me Prescription Savings Program. Your doctor, nurse, or social worker can help determine if you qualify.
  2. Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
  3. Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
  4. Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Apply at AZ&Me Prescription Savings Program →

Check If You Qualify

Use our free Assistance Finder tool to check eligibility for AZ&Me Prescription Savings Program and other programs that may help reduce your medication costs.

Open Assistance Finder

Frequently Asked Questions

What is the income limit for AZ&Me?

AZ&Me generally requires household income to be at or below 400% of the Federal Poverty Level. For a single individual in 2026, that is approximately $60,240 per year. Income thresholds may vary by specific program.

Does AZ&Me cover Farxiga and Symbicort?

Yes, both Farxiga (dapagliflozin) and Symbicort (budesonide/formoterol) are covered by AZ&Me. Eligible uninsured patients can receive these medications at no cost.

How long does AZ&Me approval take?

Most applications are reviewed within 2 to 4 weeks. Once approved, patients receive a 90-day supply of medication, and must reapply periodically to continue receiving benefits.